Search alternatives:
point decrease » point increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
point decrease » point increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
-
39281
Data Sheet 1_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont...
Published 2025“…Background<p>Chronic coronary syndromes (CCS) is a common clinical condition that increases the risk of cardiovascular events at any time. …”
-
39282
Data Sheet 2_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont...
Published 2025“…Background<p>Chronic coronary syndromes (CCS) is a common clinical condition that increases the risk of cardiovascular events at any time. …”
-
39283
Data Sheet 3_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont...
Published 2025“…Background<p>Chronic coronary syndromes (CCS) is a common clinical condition that increases the risk of cardiovascular events at any time. …”
-
39284
Data Sheet 4_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont...
Published 2025“…Background<p>Chronic coronary syndromes (CCS) is a common clinical condition that increases the risk of cardiovascular events at any time. …”
-
39285
Body surface distribution of T wave alternans is modulated by heart rate and ventricular activation sequence in patients with cardiomyopathy - Fig 7
Published 2019“…The TWA magnitude decreases by ~1.5 uV with each subsequent 10 bpm increase in rate, causing TWA magnitude to fall below clinical significance at 120 bpm. …”
-
39286
-
39287
-
39288
Heterogeneous species increases over time due to continuous binding of Aβ42 to the neurites.
Published 2013“…The green shaded sections represent the percentage of homogeneous Aβ40 in total Aβ40 species, and show the fraction of homogeneous Aβ40 to decrease over time. …”
-
39289
-
39290
-
39291
-
39292
-
39293
-
39294
-
39295
-
39296
Data_Sheet_1_A Dynamically Downscaled Ensemble of Future Projections for the California Current System.pdf
Published 2021“…To capture model uncertainty in the projections, we downscale three ESMs: GFDL-ESM2M, HadGEM2-ES, and IPSL-CM5A-MR, which span the CMIP5 range for future changes in both the mean and variance of physical and biogeochemical CCS properties. …”
-
39297
A model predicting the effects of phosphorylating different sites on the PDFR CT on downstream signaling.
Published 2022“…Other sites are also effective, although to lesser degrees (as indicated by their font sizes), including CL2-3, CL4 and CL5. Primarily, such phosphorylation will decrease the duration of PDFR signaling (red bars) and so reduce (for example) the delay that PDF imposes on the period of neuronal activation displayed by PDFR-responsive pacemaker groups (like the Evening cells and the DN3 [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1010013#pgen.1010013.ref010" target="_blank">10</a>, <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1010013#pgen.1010013.ref019" target="_blank">19</a>]). …”
-
39298
Computational design of substrate selective inhibition
Published 2020“…One is a competitive inhibitor of Ang-III (increases its K<sub>m</sub>), but non-competitive towards TRH (decreases its V<sub>max</sub>).…”
-
39299
-
39300
CORT Protein Becomes a Target of the APC/C after the Completion of Meiosis
Published 2007“…<div><p>(A) Developmental western blot showing rapid drop in CORT levels in wild-type unfertilized eggs compared to stage 14 oocytes. …”